Avexegen Therapeutics

Novel peptide therapies to treat inflammatory bowel disease (IBD) and necrotizing enterocolitis (NEC).

placeSan Francisco, California, United States calendar_todayFounded 2015 language avexegen.com

Innovation

2 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 4 times.

YearFilings
20231
20241
20251

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital125%
Accelerator & incubator125%
Other / undisclosed250%
Coming soon